Infections increasing globally

Global increases in cases

Cases, increased for past 8 weeks

Cases, + 5.2 million (7 days)

Deaths increased for past 5 weeks

Deaths, + 83,000 (7 days) up 7% on last week

South-East Asia, India, Western Pacific Region

United Arab Emirates

Population 9.8 million

Sinopharm and Pfizer

At least one dose, 65%

Two doses, 38%

Considering restricting movements of unvaccinated

National Emergency Crisis and Disasters Management

Delaying or refraining from taking the vaccine will pose a threat to the safety of society … as it poses a major challenge to the national efforts to recover

strict measures are being considered

restrict the movement of unvaccinated individuals

implement preventive measures such as restricting entry to some places and having access to some services

Israel

Some indoor venues, theatres and restaurants

Italy

National government decree, that if a health care worker, hospitals, nursing homes, or other facilities where they are in contact with patients

Then they have to accept a different work position with no contact with patients, or they will be dismissed.

Introducing Green Pass while waiting for the official EU health passport

Indian airline flight, Delhi to Hong Kong, 4th April

Up to 188 passengers

All tested negative within 72 hours of boarding

53 tested positive

Emerged during mandatory three-week quarantine

Also several cases from Mumbai flights

Introduced an emergency 2 week ban on flights from India, Pakistan and the Philippines

Brazil

Johnson & Johnson coronavirus vaccine, EMA, 20th April

Confirms positive risk benefit analysis

Concluded that a warning about unusual blood clots with low blood platelets should be added to the product information

Should be listed as very rare side effect of the vaccine

Based on 7 million vaccinations in the US, 8 cases

All cases occurred in people under 60

Within three weeks after vaccination

The majority in women

Specific risk factors have not been confirmed

Plausible explanation, an immune response, similar to heparin induced thrombocytopenia, HIT

Report for senior review

Shortness of breath

Chest pain

Leg swelling

Persistent abdominal (belly) pain

Neurological symptoms, such as severe and persistent headaches or blurred vision

Tiny blood spots under the skin beyond the site of the injection